Significance of soluble interleukin-2 recept r in patients with hemophagocytic lymphohistiocytosis

Leukemia and Lymphoma

Volumn 52, Issue 7, 2011, Pages 1360-1362

  Zhang, Lijuan ^a   Zhang, Sujiang ^a   Xu, Ji ^a   Hu, Yixin ^a   Wang, Lingling ^a   Zhang, Xiaoyan ^a   Xu, Wei ^a   Liu, Peng ^a   Qiu, Hongxia ^a   Li, Jianyong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FIBRINOGEN; GLUCOCORTICOID; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR; PREDNISONE; TRIACYLGLYCEROL; VINCRISTINE;

BLOOD SAMPLING; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LETTER; LEUKOCYTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SPLENOMEGALY; THROMBOCYTE;

HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KAPLAN-MEIER ESTIMATE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PROGNOSIS; SOLUBILITY;

EID: 79959590838     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.566394     Document Type: Letter

References (8)

1. Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008;51:402-404.
2. Gonzalo DH, Rodriguez G, Marcilla D. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus. J Pediatr Hematol Oncol 2007;29:206-207. (Pubitemid 46673413)
3. Créput C, Galicier L, Buyse S, et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med 2008;34:1177-1187.
4. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-131. (Pubitemid 44958267)
5. Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 2008;83: 747-749.
6. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990;113:619-627. (Pubitemid 20346191)
7. Imashuku S, Hibi S, Tabata Y, et al. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1998;31:131-137. (Pubitemid 28387908)
8. Imashuku S, Hibi S, Sako M, et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lyrnphohistiocytosis. Blood 1995;86:4706-4707.